Nanoporous hydroxyapatite/sodium titanate bilayer on titanium implants for improved osteointegration.

OBJECTIVE: The aim of this study was to improve the strength and quality of the titanium-hydroxyapatite interface in order to prevent long-term failure of the implanted devices originating from coating delamination and to test it in an in-vivo model. METHODS: Ti disks and dental commercial implants were etched in Kroll solution. Thermochemical treatments of the acid-etched titanium were combined with sol-gel hydroxyapatite (HA) coating processes to obtain a nanoporous hydroxyapatite/sodium titanate bilayer. The sodium titanate layer was created by incorporating sodium ions onto the Ti surface during a NaOH alkaline treatment and stabilized using a heat treatment. HA layer was added by dip-coating in a sol-gel solution. The bioactivity was assessed in vitro with murine MC3T3-E1 and human SaOs-2 cells. Functional and histopathological evaluations of the coated Ti implants were performed at 22, 34 and 60days of implantation in a dog lower mandible model. RESULTS: Nanoporous hydroxyapatite/sodium titanate bilayer on titanium implants was sensitive neither to crack propagation nor to layer delamination. The in vitro results on murine MC3T3-E1 and human SaOs-2 cells confirm the advantage of this coating regarding the capacity of cell growth and differentiation. Signs of progressive bone incorporation, such as cancellous bone formed in contact with the implant over the existing compact bone, were notable as early as day 22. Overall, osteoconduction and osteointegration mean scores were higher for test implants compared to the controls at 22 and 34 days. SIGNIFICANCE: Nanoporous hydroxyapatite/sodium titanate bilayer improves the in-vivo osteoconduction and osteointegration. It prevents the delamination during the screwing and it could increase HA-coated dental implant stability without adhesive failures. The combination of thermochemical treatments with dip coating is a low-cost strategy.

Detection of melanomas. Approach with radiolabeled false precursors of melanin synthesis.

Thiouracil is a thiol-containing pyrimidine that is selectively incorporated into cells that synthesize melanin. In an effort to delineate further the specificity and dynamics of uptake, we injected thiouracil labeled with radioactive carbon into S91 melanoma-bearing mice; biopsy specimens were taken of the tumors and organs at various time intervals thereafter. The data showed a substantial uptake of thiouracil by the melanomas, with peak uptake occurring at 24 hours. All other organs examined showed only minor amounts of radioactivity, which probably reflected the presence of thiouracil in the blood perfusing these tissues. Because of its incorporation into melanomas, the use of radioactive thiouracil has potential as a marker for tumor growth, as a diagnostic tracer compound, and as a carrier for chemotherapeutic agents.

Animal model of intracutaneous melanoma.

An animal model which allows for the implantation and development of intracutaneous melanoma is described. Intradermal vesicles are created by a negative pressure apparatus in DBA/2J mice. S91 melanoma cells are injected into the blister cavities. Tumor growth occurs within 7 days and the yield approaches 100%. This model is a rapid, efficient, and applicable system for the study of melanoma growth dynamics and of the effects of systemic and topical anti-tumor agents on melanoma proliferation.